Φορτώνει......
Complement in cancer: untangling an intricate relationship
In tumour immunology, complement has traditionally been considered as an adjunctive component that enhances the cytolytic effects of antibody-based immunotherapies, such as rituximab. Remarkably, research in the past decade has uncovered novel molecular mechanisms linking imbalanced complement activ...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Nat Rev Immunol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5816344/ https://ncbi.nlm.nih.gov/pubmed/28920587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nri.2017.97 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|